[SCHEDULE 13G] Envoy Medical, Inc. SEC Filing
Alta Partners LLC filed a Schedule 13G reporting beneficial ownership of 1,944,139 shares of Envoy Medical, Inc. Class A common stock (shares issuable upon exercise of warrants), representing 8.25% of the class. Alta Partners reports sole voting and dispositive power over these shares and certifies the position was acquired and is held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Alta Partners LLC ha presentato un Schedule 13G segnalando la titolarit脿 beneficiaria di 1,944,139 azioni di Envoy Medical, Inc. Classe A (azioni emesse al momento dell'esercizio di warrant), corrispondenti al 8.25% della classe. Alta Partners dichiara di avere il pieno potere di voto e di disposizione su queste azioni e certifica che la posizione 猫 stata acquisita e viene detenuta nell'ordinario corso dell'attivit脿 e non con l'intento di modificare o influenzare il controllo dell'emittente.
Alta Partners LLC present贸 un Schedule 13G informando la propiedad beneficiaria de 1,944,139 acciones de Envoy Medical, Inc. clase A de acciones ordinarias (acciones susceptibles de emitirse al ejercer warrants), que representan el 8.25% de la clase. Alta Partners declara tener el poder exclusivo de voto y de disposici贸n sobre estas acciones y certifica que la posici贸n fue adquirida y se mantiene en el curso ordinario del negocio y no con el prop贸sito de cambiar o influir en el control del emisor.
Alta Partners LLC電� Schedule 13G毳� 鞝滌稖頃橃棳 Envoy Medical, Inc. 韥措灅鞀� A 氤错喌欤� 1,944,139欤�(鞗岆煱韸� 頄夓偓搿� 氚滍枆 臧�電ロ暅 欤检嫕)毳� 鞁れ鞝侅溂搿� 氤挫湢頃橁碃 鞛堨潓鞚� 氤搓碃頄堨溂氅�, 鞚措姅 頃措嫻 韥措灅鞀れ潣 8.25%鞐� 頃措嫻頃╇媹雼�. Alta Partners電� 鞚� 欤检嫕霌れ棎 雽�頃� 雼弲 鞚橁舶甓� 氚� 觳橂秳甓�鞚� 氤挫湢頃橁碃 鞛堨潓鞚� 氤搓碃頃橁碃, 頃措嫻 歆�攵勳澊 鞓侅梾鞚� 鞝曥儊鞝侅澑 瓿检爼鞐愳劀 旆摑路氤挫湢霅� 瓴冹瀯鞚� 攴鸽Μ瓿� 氚滍枆鞚胳潣 歆�氚瓣秾鞚� 氤�瓴巾晿瓯半倶 鞓來枼霠レ潉 頄夓偓頃� 氇╈爜鞚� 鞎勲嫎鞚� 鞚胳頃╇媹雼�.
Alta Partners LLC a d茅pos茅 un Schedule 13G d茅clarant la propri茅t茅 b茅n茅ficiaire de 1,944,139 actions ordinaires de cat茅gorie A d'Envoy Medical, Inc. (actions susceptibles d'锚tre 茅mises lors de l'exercice de bons), repr茅sentant 8,25% de la cat茅gorie. Alta Partners indique d茅tenir sur ces actions le pouvoir exclusif de vote et de disposition et certifie que la position a 茅t茅 acquise et est d茅tenue dans le cours normal des affaires et non dans le but de modifier ou d'influencer le contr么le de l'茅metteur.
Alta Partners LLC hat ein Schedule 13G eingereicht und meldet die wirtschaftliche Eigent眉merschaft an 1,944,139 Aktien der Envoy Medical, Inc. Klasse A Stammaktien (Aktien, die bei Aus眉bung von Warrants ausgegeben werden k枚nnen), was 8,25% der Klasse entspricht. Alta Partners berichtet, dass es 眉ber diese Aktien alleinige Stimm- und Verf眉gungsgewalt besitzt und best盲tigt, dass die Position im normalen Gesch盲ftsverlauf erworben und gehalten wird und nicht zum Zweck der 脛nderung oder Beeinflussung der Kontrolle des Emittenten dient.
- Material disclosure of a >5% position (1,944,139 shares, 8.25%) providing transparency to the market
- Sole voting and dispositive power reported for all shares, clarifying who controls votes and disposition
- Certification that the shares were acquired in the ordinary course and not to change control
- None.
Insights
TL;DR: A significant disclosure: Alta Partners reports an >5% warrant-derived stake and sole control of votes and disposition.
Alta Partners' filing shows a material equity position in Envoy Medical equal to 8.25% of Class A stock, derived from shares issuable on exercise of warrants. The filer asserts sole voting and dispositive power, which means Alta can direct voting and disposition of these shares if exercised. The certification that the position is not intended to change control is a standard compliance statement; it limits but does not eliminate governance implications if warrants are exercised and shares are used actively.
TL;DR: Ownership is material for investors and governance monitoring but the filer disclaims control intent.
The reported 8.25% stake is above the 5% Schedule 13G threshold, triggering public disclosure requirements and investor scrutiny. Sole voting and dispositive power over 1,944,139 shares gives Alta Partners practical influence if the warrants convert to voting shares. The explicit certification that the holdings are not intended to affect control reduces immediate takeover concerns, yet this position warrants monitoring for any future Form 13D amendments or changes in intent.
Alta Partners LLC ha presentato un Schedule 13G segnalando la titolarit脿 beneficiaria di 1,944,139 azioni di Envoy Medical, Inc. Classe A (azioni emesse al momento dell'esercizio di warrant), corrispondenti al 8.25% della classe. Alta Partners dichiara di avere il pieno potere di voto e di disposizione su queste azioni e certifica che la posizione 猫 stata acquisita e viene detenuta nell'ordinario corso dell'attivit脿 e non con l'intento di modificare o influenzare il controllo dell'emittente.
Alta Partners LLC present贸 un Schedule 13G informando la propiedad beneficiaria de 1,944,139 acciones de Envoy Medical, Inc. clase A de acciones ordinarias (acciones susceptibles de emitirse al ejercer warrants), que representan el 8.25% de la clase. Alta Partners declara tener el poder exclusivo de voto y de disposici贸n sobre estas acciones y certifica que la posici贸n fue adquirida y se mantiene en el curso ordinario del negocio y no con el prop贸sito de cambiar o influir en el control del emisor.
Alta Partners LLC電� Schedule 13G毳� 鞝滌稖頃橃棳 Envoy Medical, Inc. 韥措灅鞀� A 氤错喌欤� 1,944,139欤�(鞗岆煱韸� 頄夓偓搿� 氚滍枆 臧�電ロ暅 欤检嫕)毳� 鞁れ鞝侅溂搿� 氤挫湢頃橁碃 鞛堨潓鞚� 氤搓碃頄堨溂氅�, 鞚措姅 頃措嫻 韥措灅鞀れ潣 8.25%鞐� 頃措嫻頃╇媹雼�. Alta Partners電� 鞚� 欤检嫕霌れ棎 雽�頃� 雼弲 鞚橁舶甓� 氚� 觳橂秳甓�鞚� 氤挫湢頃橁碃 鞛堨潓鞚� 氤搓碃頃橁碃, 頃措嫻 歆�攵勳澊 鞓侅梾鞚� 鞝曥儊鞝侅澑 瓿检爼鞐愳劀 旆摑路氤挫湢霅� 瓴冹瀯鞚� 攴鸽Μ瓿� 氚滍枆鞚胳潣 歆�氚瓣秾鞚� 氤�瓴巾晿瓯半倶 鞓來枼霠レ潉 頄夓偓頃� 氇╈爜鞚� 鞎勲嫎鞚� 鞚胳頃╇媹雼�.
Alta Partners LLC a d茅pos茅 un Schedule 13G d茅clarant la propri茅t茅 b茅n茅ficiaire de 1,944,139 actions ordinaires de cat茅gorie A d'Envoy Medical, Inc. (actions susceptibles d'锚tre 茅mises lors de l'exercice de bons), repr茅sentant 8,25% de la cat茅gorie. Alta Partners indique d茅tenir sur ces actions le pouvoir exclusif de vote et de disposition et certifie que la position a 茅t茅 acquise et est d茅tenue dans le cours normal des affaires et non dans le but de modifier ou d'influencer le contr么le de l'茅metteur.
Alta Partners LLC hat ein Schedule 13G eingereicht und meldet die wirtschaftliche Eigent眉merschaft an 1,944,139 Aktien der Envoy Medical, Inc. Klasse A Stammaktien (Aktien, die bei Aus眉bung von Warrants ausgegeben werden k枚nnen), was 8,25% der Klasse entspricht. Alta Partners berichtet, dass es 眉ber diese Aktien alleinige Stimm- und Verf眉gungsgewalt besitzt und best盲tigt, dass die Position im normalen Gesch盲ftsverlauf erworben und gehalten wird und nicht zum Zweck der 脛nderung oder Beeinflussung der Kontrolle des Emittenten dient.
FAQ
What stake does Alta Partners LLC report in Envoy Medical (COCH)?
Are the reported shares currently outstanding common stock or related to warrants?
Does Alta Partners assert voting or dispositive control over the reported shares?
Does Alta Partners intend to influence control of Envoy Medical (COCH)?
When was the Schedule 13G signed and by whom?
